➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
Medtronic
Express Scripts
Harvard Business School

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DORZAGLIATIN


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Clinical Trials for Dorzagliatin

Trial ID Title Status Sponsor Phase Summary
NCT03790787 Drug Interaction Study Between Dorzagliatin and Empagliflozin Not yet recruiting Hua Medicine Limited Phase 1 This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and empagliflozin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and empagliflozin given alone and in combination will be studied.
NCT03790839 Drug Interaction Study Between Dorzagliatin and Sitagliptin Not yet recruiting Hua Medicine Limited Phase 1 This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and sitagliptin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and sitagliptin given alone and in combination will be studied.
NCT04080596 DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin Completed Hua Medicine Limited Phase 1 The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin.
NCT04080609 DDI Study Between Dorzagliatin and Rifampicin Completed Hua Medicine Limited Phase 1 The purpose of this drug-drug interaction study is to investigate the impact of rifampicin on the pharmacokinetics of Dorzagliatin.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Dorzagliatin

Condition Name

Condition Name for
Intervention Trials
Patients 2
Drug Interaction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dorzagliatin

Trials by Country

Trials by Country for
Location Trials
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dorzagliatin

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Not yet recruiting 2
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dorzagliatin

Sponsor Name

Sponsor Name for
Sponsor Trials
Hua Medicine Limited 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Johnson and Johnson
Dow
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.